Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-dendrimersome
- Development stage
- Preclinical
- Lead developer
- Aix-Marseille University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
68Ga-dendrimersome is a gallium-68 radiolabeled, self-assembling supramolecular dendrimersome formulation developed as a positron emission tomography (PET) imaging agent. Designed by researchers at Aix-Marseille University, this nanoradiotracer is engineered to evaluate the heterogeneity of the enhanced permeability and retention (EPR) effect in solid tumors. By utilizing the passive targeting properties of its nanoparticle structure, 68Ga-dendrimersome accumulates in tumor tissues, allowing for highly sensitive and specific PET imaging of cancers, including those with low glucose uptake that are typically refractory to standard 18F-FDG imaging. Preclinical pharmacokinetic and biodistribution studies have focused on optimizing the dendrimersome formulation to minimize healthy organ exposure and accelerate renal clearance.
- Other names
- 68Ga-168Ga-labeled dendrimersome[68Ga]Ga-1[68Ga]Ga-dendrimersomegallium-68 dendrimersomegallium68 dendrimersomegallium 68 dendrimersome
Beyond the preview
Go deeper on 68Ga-dendrimersome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-dendrimersome.